Showing 2971-2980 of 6035 results for "".
- Pharma Company Exercises Rights for Exclusive Use of Everads Drug Delivery Technology in Specific Retinal Targetshttps://modernod.com/news/pharma-company-exercises-rights-for-exclusive-use-of-everads-drug-delivery-technology-in-specific-retinal-targets/2478193/Everads Therapy has granted a pharmaceutical company a time-limited exclusivity for utilizing Everads’ suprachoroidal delivery technology for the development of specific ocular targets. In exchange for exclusivity of these specific ocular targets, Everads will receive a milestone payment. E
- LensGen Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directorshttps://modernod.com/news/lensgen-closes-10-million-financing-and-welcomes-james-v-mazzo-to-its-board-of-directors/2478182/LensGen announced the initial closing of a $10 million of the $20 million Bridge Financing and announcd the election of James Mazzo to its Board of Directors.
- Safer and More Effective Glaucoma Surgical Options Will Drive Surgery Device Treatment Penetration Over Next Five Yearshttps://modernod.com/news/safer-and-more-effective-glaucoma-surgical-options-will-drive-surgery-device-treatment-penetration-over-next-five-years/2478181/Expanding use of surgical devices in patients with all stages of glaucoma will increase the role of surgery in the glaucoma treatment paradigm over the next 5 years, according to a Market Scope report. There are four FDA-approved minimally invasive glaucoma surgery (MIGS) stents in the US:
- Patient Safety Advocate Group Calls for Congressional Action to Prevent Implementation of Contact Lens Rulehttps://modernod.com/news/patient-safety-advocate-group-calls-for-congressional-action-to-prevent-implementation-of-contact-lens-rule/2478178/The Health Care Alliance for Patient Safety (APS) released the following statement regarding the Federal Trade Commission’s (FTC) publication of the Contact Lens Rule in the Federal Register. The rule
- Bausch + Lomb Launches Infuse Silicone Hydrogel (SIHY) Daily Disposable Contact Lenseshttps://modernod.com/news/bausch-lomb-launches-infuse-silicone-hydrogel-sihy-daily-disposable-contact-lenses/2478170/Bausch + Lomb announced the launch of Bausch + Lomb Infuse silicone hydrogel (SiHy) daily disposable contact lens. The Infuse lenses feature a next generation material infused with ProBalance Technology to help maintain ocular surface homeostasis and help reduce symptoms of contact lens dryness,
- Sanofi Enters $3.7-Billion Deal to Buy Principia Biopharmahttps://modernod.com/news/sanofi-enters-3-7-billion-deal-to-buy-principia-biopharma/2478166/Sanofi announced Monday a definitive agreement to acquire all of Principia Biopharma’s outstanding stock for $100 per share in cash, representing an equity value of around $3.7 billion, boosting the French drugmaker’s core research areas of autoimmune and allergic diseases. The deal,
- Multifocal Contact Lenses With High Add Power Help Slow Myopia Progressionhttps://modernod.com/news/multifocal-contact-lenses-with-high-add-power-help-slow-myopia-progression/2478162/Soft multifocal contact lenses with a high add power help slow progression of myopia in children, more so than multifocal lenses with medium add power or single-vision lenses, according to results of the BLINK trial, Reuters reported.
- TearClear Raises $22M in Series B Fundinghttps://modernod.com/news/tearclear-raises-22m-in-series-b-funding/2478158/TearClear announced it has raised $22 million in a Series B funding round. The company intends to use the funds to advance multiple clinical programs in development, with two lead candidates in glaucoma paving the way for future indications. Led by Chief Executive Officer Robert Dempsey, T
- US Secures At Least 100 Million Doses of Moderna’s COVID-19 Vaccine for $1.5 Billionhttps://modernod.com/news/us-secures-at-least-100-million-doses-of-modernas-covid-19-vaccine-for-1-5-billion/2478151/Moderna on Tuesday said it reached an agreement with the US government to supply millions of doses of its coronavirus vaccine candidate mRNA-1273. The award of up to $1.525 billion is for the manufacturing and delivery of 100 million doses of the vaccine, including incentive payments for timely d
- Health Canada Approves Bausch + Lomb Ultra One Day Silicone Hydrogel Daily Disposable Contact Lenseshttps://modernod.com/news/health-canada-approves-bausch-lomb-ultra-one-day-silicone-hydrogel-daily-disposable-contact-lenses/2478142/Bausch + Lomb announced that it has received approval from Health Canada for the sale of Bausch + Lomb Ultra One Day daily disposable silicone hydrogel (SiHy daily) contact lenses. Bausch + Lomb Ultra One Day contact lenses feature a next generation contact lens material (kalifilcon A) wit